ACC's new Cardio Safe initiative, launching this fall, will help cardiologists and cardiovascular professionals address patient- and visitor-initiated mistreatment while fostering safer, more respectful and psychologically secure clinical care environments.

It takes longer than we'd like to gain confidence in new percutaneous technology. Twenty years after Andreas Grüntzig's first coronary PTCA, we were still debating whether stents were good or bad. Now we're wondering about a return to balloons alone – albeit drug-coated. So it has been with left atrial appendage occlusion (LAAO).

Left atrial appendage occlusion (LAAO) has become the most performed structural heart procedure in the U.S., with an estimated >700,000 procedures completed to date and volumes climbing sharply every year.

The ACC was live from ESC Congress 2026 in Munich, bringing members the latest cardiovascular science and clinical guidance. Below are standout studies in heart failure (HF), structural heart disease, dyslipidemia and prevention, and more, plus promising news in pulmonary embolism (PE).

For many patients with postural orthostatic tachycardia syndrome (POTS), a form of dysautonomia, simply standing can trigger palpitations, dizziness, fatigue and exercise intolerance.

Twenty-five years ago, cardiovascular leaders faced a very different landscape. Independent cardiology practices were flourishing, fee-for-service reimbursement dominated, and consolidation, digital transformation and payment reform had yet to reshape the specialty.